1Forrest FC, Tooley MA, Saunders PR, et al. Propofol infusion and the suppression of consciousness: the EEG and dose requirements. Br J Anaesth, 1994,72: 35-41.
2Smith C, McEwan AI, Jhaveri R, et al. The interaction of fentanyl on Cp50 of propofol for loss of consciousndss and skin ineision.Anesthesiology, 1994,81: 820-828.
3Swinhoe CF, Peacock JE, Glen JB, et al. Evaluation of the predictive performance of a 'Diprifusor' TCI system. Anaesthesia, 1998,53(Suppl1): 61-67.
4Kirkpatrick T, Cockshott ID, Douglas FJ, et al. Pharmacokinetics of propofol (Diprivan) in elderly patients. Br J Anaesth, 1988, 60: 146-150.
5Scott JC, Ponganis KV, Stanski DR. EEG quantitation of narcotic effect:The comparative pharmacodynamics of fentanyl and alfentanil.Anesthesiology, 1985, 62:234-241.
6Kazama T, Ikeda K, Morita K. The pharmacodynamic interaction between propofol and fentanyl with respect to the suppression of somatic or hemodynamic responses to skin incision, peritoneum incision, abdominal wall retraction. Anesthesiology, 1998, 89:894-906.
7Stanley TH, Webster LR. Anesthetic requirements and cardiovascular eftects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man.Anesth Analg, 1978, 57: 411.
8Foxex P. Cardiovascular effects of propofol. J Drug Dev, 1991, 4:3-49.
9Mcquay HJ, Stoeckel H. Plasma fentanyl concentration and clinical observations during and after operation. Br J Anaesth, 1979, 51: 543.
